{
  "docId": "019de073-d0ca-7288-9ab4-c51009336f37",
  "docSlug": "2ef2fad38453444b0a07cd5e908bf527",
  "documentTitle": "PaxMedica | Investor Presentation Deck | 24 slides",
  "authorId": "paxmedica",
  "authorName": "PaxMedica",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 22,
  "pageCount": 24,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a human-centric image to emphasize the clinical impact of the drug.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-d0ca-7288-9ab4-c51009336f37/22",
  "deckHref": "/decks/019de073-d0ca-7288-9ab4-c51009336f37",
  "deckJsonHref": "/decks/019de073-d0ca-7288-9ab4-c51009336f37.json",
  "deckAnchorHref": "/decks/019de073-d0ca-7288-9ab4-c51009336f37#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.03,
        "y": 0.96
      },
      "kind": "disclaimer",
      "text": "© 2022. PaxMedica, Inc. Proprietary Information. All rights reserved",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e941a3e-fd15-41e9-8d43-f41425246c03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 1,
        "w": 0.4,
        "x": 0.6,
        "y": 0
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb3af2da-6bf0-478b-bafd-849c885721dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.6,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "Both dose regimens showed improvement trends from baseline on ABC Core, but study was not statistically powered\n10 mg/kg dose group showed a statistically significant and clinically meaningful change on the CGI-I\nConfirmation of these results needed in a larger study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bfb40a5-9386-4b28-822b-faa14e69b5d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "PAX-101 – Phase 2 Trial Summary Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e033bccb-70c7-4986-967c-e0f65ca4ac5b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}